All News about Astrazeneca Plc ADR![]() ![]() ![]() ![]() ![]() ![]()
PhaseBio Might Have To Return Global Rights To Its Lead Program
September 28, 2022
Via Benzinga
![]()
Japan Approves AstraZeneca's Two Treatments For Asthma, Rare Form Of Cancer
September 27, 2022
Via Benzinga
![]() ![]() ![]() ![]() ![]()
Central Nervous System Disorders Therapeutics Market Expected to Reach $159 Billion by 2028
October 12, 2022
Exposures
COVID-19
![]() Via Benzinga
![]() ![]() ![]() ![]() ![]()
Is Illumina Still the Gamechanger in Genomics Sequencing?
October 04, 2022
Via MarketBeat
![]() ![]() ![]() ![]() ![]() ![]()
Why Are LogicBio Therapeutics Shares Skyrocketing Today?
October 03, 2022
Via Benzinga
![]() ![]() Via Benzinga
![]() ![]() ![]()
US Stock Futures Rise Ahead Of Economic Reports, Fed Speakers; Crude Oil Rises 1%
September 27, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|